C07D 241/10
Having three double bonds between ring members or between ring members and
Official title: having three double bonds between ring members or between ring members and non-ring members
C07D241/10 (Having three double bonds between ring members or between ring members and) appears on 2,320 US grants and 2,351 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,320
- Published applications
- 2,351
- Assignees
- 963
- Inventors
- 7,253
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 22 | 0 |
| 1977 | 14 | 0 |
| 1978 | 21 | 0 |
| 1979 | 18 | 0 |
| 1980 | 18 | 0 |
| 1981 | 12 | 0 |
| 1982 | 12 | 0 |
| 1983 | 9 | 0 |
| 1984 | 18 | 0 |
| 1985 | 22 | 0 |
| 1986 | 24 | 0 |
| 1987 | 31 | 0 |
| 1988 | 31 | 0 |
| 1989 | 33 | 0 |
| 1990 | 39 | 0 |
| 1991 | 31 | 0 |
| 1992 | 33 | 0 |
| 1993 | 24 | 0 |
| 1994 | 26 | 0 |
| 1995 | 26 | 0 |
| 1996 | 30 | 0 |
| 1997 | 48 | 0 |
| 1998 | 34 | 0 |
| 1999 | 49 | 0 |
| 2000 | 41 | 0 |
| 2001 | 50 | 8 |
| 2002 | 50 | 57 |
| 2003 | 42 | 97 |
| 2004 | 42 | 105 |
| 2005 | 45 | 95 |
| 2006 | 46 | 71 |
| 2007 | 53 | 79 |
| 2008 | 52 | 79 |
| 2009 | 43 | 100 |
| 2010 | 56 | 113 |
| 2011 | 63 | 99 |
| 2012 | 85 | 90 |
| 2013 | 74 | 100 |
| 2014 | 104 | 125 |
| 2015 | 111 | 125 |
| 2016 | 83 | 100 |
| 2017 | 100 | 121 |
| 2018 | 85 | 92 |
| 2019 | 84 | 108 |
| 2020 | 83 | 97 |
| 2021 | 57 | 84 |
| 2022 | 56 | 88 |
| 2023 | 49 | 116 |
| 2024 | 47 | 82 |
| 2025 | 55 | 73 |
| 2026 | 39 | 47 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Method for preparing 3,6-diaminopyrazine-2,5-dicarboxylic acid and synthetic intermediate thereof28 Jul 2026US 12,692,240 B2MediBeacon Inc.
- Aptamer nucleic acid molecule, and complex and application thereof23 Jun 2026US 12,662,676 B2East China University of Science and Technology
- Bicyclic compounds8 Oct 2026US 2026/0308114 A1Vivace Therapeutics, Inc.
- Pyrazinecarboxamide analog compounds for use in treating cancer1 Oct 2026US 2026/0297064 A1Novapano LLC
- Modulators of sortilin activity24 Sep 2026US 2026/0285802 A1
- Phenolic compounds blocking nav 1.7 and/or nav 1.8, processes for the preparation thereof, compositions, uses, methods of treatment using same and kits17 Sep 2026US 2026/0274804 A1Eurofarma Laboratorios SA
- Compound serving as ddr1 kinase inhibitor, and medicine20 Aug 2026US 2026/0242343 A1Nippon Shinyaku Co., Ltd.
Most cited
By later US patents
- Light-emitting element192US 9,604,928 B2Semiconductor Energy Laboratory Co.Ltd. · 2017
- Glutaramide diuretic agents156US 5,030,654 APfizer Inc. · 1991
- Transfection reagents155US 7,479,573 B2Invitrogen Corporation · 2009
- N-indanyl carboxamide derivative and agricultural/horticultural fungicide containing the derivative as active ingredient141US 4,914,097 AMitsubishi Kasei Corporation · 1990
- Compounds and compositions for delivering active agents116US 5,773,647 AEmisphere Technologies, Inc. · 1998